Related Articles
MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells
MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion
The MEK inhibitor PD98059 attenuates growth inhibition and death in gallic acid-treated Calu-6 lung cancer cells by preventing glutathione depletion
Effects of antioxidants and MAPK inhibitors on cell death and reactive oxygen species levels in H2O2‑treated human pulmonary fibroblasts
MAPK inhibitors enhance cell death in pyrogallol-treated human pulmonary fibroblast cells via increasing O2•‑ levels